CN114323863B - Preparation method and application of exosome array capture probe - Google Patents
Preparation method and application of exosome array capture probe Download PDFInfo
- Publication number
- CN114323863B CN114323863B CN202111661780.0A CN202111661780A CN114323863B CN 114323863 B CN114323863 B CN 114323863B CN 202111661780 A CN202111661780 A CN 202111661780A CN 114323863 B CN114323863 B CN 114323863B
- Authority
- CN
- China
- Prior art keywords
- amphiphilic
- probe
- minutes
- exosome
- phosphate buffer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
技术领域Technical field
本发明属于外泌体捕获及检测领域,尤其涉及一种外泌体阵列捕获探针的制备方法与应用。The invention belongs to the field of exosome capture and detection, and in particular relates to a preparation method and application of an exosome array capture probe.
背景技术Background technique
外泌体(Exosome)是直径范围在40~160nm的具有脂质双分子层膜结构的一种细胞外囊泡。目前外泌体在细胞间通讯和细胞免疫应答中发挥的重要作用已经逐渐被发现,它不仅携带有发挥生物学功能的有效成分(脂质、蛋白质和遗传物质等)同时还携带参与了细胞通讯、血管新生、细胞迁移、心血管疾病发生、神经退行性疾病以及肿瘤细胞生长等生理和病理过程的多种成分,对外泌体进行捕获及检测具有很高的研究意义。Exosomes are extracellular vesicles with a lipid bilayer membrane structure ranging from 40 to 160 nm in diameter. At present, the important role played by exosomes in intercellular communication and cellular immune response has been gradually discovered. They not only carry active ingredients (lipids, proteins, genetic materials, etc.) that perform biological functions, but also carry components involved in cell communication. , angiogenesis, cell migration, cardiovascular disease, neurodegenerative diseases, tumor cell growth and other physiological and pathological processes, the capture and detection of exosomes is of high research significance.
在临床癌症诊断中,组织活检作为病理检查的一个必要的工具,具有一定的侵入性,对于病人而言痛苦程度较高。组织活检的形式不仅不适用于对病人进行动态监测,同时也加重了病人的生理和心理压力。因此液体活检这种非侵入式的活检方式从生物体液中获得所需的诊断信息就十分有必要。在液体活检的背景下,分析外泌体的内容物可以获取有关癌症的存在和分布等信息,因此,外泌体用作液体活检中的生物标志物,具有实时监测肿瘤和治疗效果。In clinical cancer diagnosis, tissue biopsy is a necessary tool for pathological examination, which is invasive and highly painful for patients. The form of tissue biopsy is not only unsuitable for dynamic monitoring of patients, but also increases the patient's physical and psychological pressure. Therefore, liquid biopsy, a non-invasive biopsy method, is necessary to obtain the required diagnostic information from biological fluids. In the context of liquid biopsy, analyzing the contents of exosomes can obtain information about the presence and distribution of cancer. Therefore, exosomes are used as biomarkers in liquid biopsies with real-time monitoring of tumors and therapeutic effects.
迄今为止已开发出许多用于外泌体分离的技术,包括依据外泌体密度和大小与细胞、细胞碎片以及其他生物干扰物之间的差异而开发的外泌体分离技术;依据外泌体的表面特异性蛋白或者是特异性结构,通过抗体免疫亲和的作用力来实现外泌体分离的技术;以及一些模拟抗原抗体之间的相互作用,通过分子识别而进行捕获分离的技术等。但是每种方法都因其自身的局限性而无法得到广泛的应用,并且还没有有方法可以满足于临床上大批量样本的外泌体平行捕获与检测。A number of technologies have been developed for exosome isolation to date, including those based on differences in exosome density and size compared with cells, cell debris, and other biological interferences; Surface-specific proteins or specific structures can be used to separate exosomes through the force of antibody immunoaffinity; as well as some technologies that simulate the interaction between antigens and antibodies and capture and separate through molecular recognition. However, each method cannot be widely used due to its own limitations, and there is no method that can satisfy the parallel capture and detection of exosomes in large batches of clinical samples.
发明内容Contents of the invention
本发明实施例的目的在于提供一种外泌体阵列捕获探针的制备方法与应用,旨在解决从足够数量和纯度的非外泌体组分中分离出它们并实现原位检测的问题。The purpose of the embodiments of the present invention is to provide a preparation method and application of an exosome array capture probe, aiming to solve the problem of isolating non-exosome components from sufficient quantities and purity and achieving in-situ detection.
本发明实施例是这样实现的,两亲性树枝状超分子探针的合成以及膜上修饰,包括如下步骤:The embodiment of the present invention is achieved as follows. The synthesis and membrane modification of amphiphilic dendritic supramolecular probes include the following steps:
1)使用二甲基亚砜溶解两性霉素B,超声促进溶解;1) Use dimethyl sulfoxide to dissolve amphotericin B, and use ultrasound to promote dissolution;
2)1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐(EDC)和N-羟基琥珀酰亚胺(NHS)溶解于MES缓冲液中;2) Dissolve 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) in MES buffer;
3)混合步骤1)和步骤2)中所得到的两种溶液,并于37℃环境中混合搅拌活化AMB分子中的羧基;3) Mix the two solutions obtained in steps 1) and 2), and mix and stir in a 37°C environment to activate the carboxyl groups in the AMB molecules;
4)向步骤3)中所得到的溶液中加入树枝状聚合物溶液,于室温环境中反应过夜;4) Add the dendrimer solution to the solution obtained in step 3) and react overnight at room temperature;
5)使用透析管对步骤4)中的溶液进行透析,通过更换水来去除多余的反应物,收集透析后的探针溶液;5) Use a dialysis tube to dialyze the solution in step 4), remove excess reactants by replacing water, and collect the dialyzed probe solution;
6)硝酸纤维素膜在水中活化,加入探针分子溶液孵育过夜,孵育完成后用MES缓冲液和磷酸盐缓冲液分别洗涤,置于室温环境中干燥;6) Activate the nitrocellulose membrane in water, add probe molecule solution and incubate overnight. After the incubation is completed, wash it with MES buffer and phosphate buffer respectively, and dry it at room temperature;
两亲性树枝状超分子探针修饰膜对体液的阵列检测,包括如下步骤:Array detection of body fluids using amphipathic dendritic supramolecular probe-modified membranes includes the following steps:
1)对体液样本进行前处理,收集到的体液样本存储于-80℃,将其置于4℃融化后,低速离心取上清进行点样;1) Pre-process the body fluid samples. The collected body fluid samples are stored at -80°C, thawed at 4°C, and then centrifuged at low speed to collect the supernatant for spotting;
2)将不同病人体液样本各1μL以阵列形式点样在两亲性树枝状超分子探针修饰的NC膜上;2) Spot 1 μL of each body fluid sample from different patients on the NC membrane modified with amphipathic dendritic supramolecular probes in array form;
3)点样后的膜在室温环境中干燥,用磷酸盐缓冲洗涤2次,每次5min;3) The spotted membrane was dried at room temperature and washed twice with phosphate buffer for 5 minutes each time;
4)将膜置于含有5%脱脂奶粉的磷酸盐缓冲液中封闭20-30min,再用含有吐温的磷酸盐缓冲液洗涤3次,每次5min;4) Block the membrane in phosphate buffer containing 5% skim milk powder for 20-30 minutes, and then wash it 3 times with phosphate buffer containing Tween, 5 minutes each time;
4)分别选取在癌症中高表达的蛋白相应抗体进行孵育,孵育条件为室温2h,或者4℃孵育过夜,孵育后使用含有吐温的磷酸盐缓冲液洗3次,每次10min;4) Select antibodies corresponding to proteins highly expressed in cancer for incubation. The incubation conditions are room temperature for 2 hours, or incubation at 4°C overnight. After incubation, wash 3 times with phosphate buffer containing Tween, 10 minutes each time;
5)使用与一抗相对应的二抗进行孵育,使用含有吐温的磷酸盐缓冲液洗3次,每次10min,并使用成像系统对蛋白信号进行定量扫描。5) Incubate with the secondary antibody corresponding to the primary antibody , wash 3 times with phosphate buffer containing Tween for 10 minutes each time, and use an imaging system to quantitatively scan the protein signal.
本发明实施例提供的一种外泌体阵列捕获探针的制备方法与应用,具有以下有益效果:The preparation method and application of an exosome array capture probe provided by the embodiments of the present invention have the following beneficial effects:
双亲性超分子能够插入到单层膜内部与与脂质和甾醇结合,利用超分子的多价协同效应实现了对外泌体的高效捕获。这种新的策略可以结合纤维素膜以反相微阵列形式对体液样本中的外泌体进行捕获,也可以针对外泌体中具有表达差异的不同的疾病标志蛋白对大批量样本进行高通量检测。我们所发展的超分子探针分析手段操作简便、灵敏度高、分析速度快,有望成为外泌体高通量富集和检测的新平台,为疾病的预警和追踪提供有力的技术支持。Amphipathic supramolecules can be inserted into the interior of a single-layer membrane and combined with lipids and sterols, utilizing the multivalent synergistic effect of the supramolecular to achieve efficient capture of exosomes. This new strategy can be combined with cellulose membranes to capture exosomes in body fluid samples in the form of reversed-phase microarrays, and can also perform high-throughput analysis of large batches of samples for different disease marker proteins with differential expression in exosomes. Quantity testing. The supramolecular probe analysis method we developed is easy to operate, has high sensitivity and fast analysis speed. It is expected to become a new platform for high-throughput enrichment and detection of exosomes, providing strong technical support for early warning and tracking of diseases.
附图说明Description of the drawings
图1为本发明实施例提供的两亲性树枝状超分子探针修饰硝酸纤维素膜对临床样本中外泌体的高通量检测图;Figure 1 is a diagram of high-throughput detection of exosomes in clinical samples using an amphiphilic dendritic supramolecular probe modified nitrocellulose membrane provided by an embodiment of the present invention;
图2为本发明实施例提供的两亲性树枝状超分子探针修饰硝酸纤维素膜对临床样本中外泌体的修饰NC膜对临床样本的高通量阵列检测图。Figure 2 is a high-throughput array detection diagram of amphiphilic dendritic supramolecular probe-modified nitrocellulose membrane for exosomes in clinical samples and a modified NC membrane for clinical samples according to the embodiment of the present invention.
具体实施方式Detailed ways
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合附图及实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。In order to make the purpose, technical solutions and advantages of the present invention more clear, the present invention will be further described in detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described here are only used to explain the present invention and are not intended to limit the present invention.
以下结合具体实施例对本发明的具体实现进行详细描述。The specific implementation of the present invention will be described in detail below with reference to specific embodiments.
实施例1:Example 1:
ADSP分子探针涂覆硝酸纤维素膜的制备及应用:Preparation and application of ADSP molecular probe-coated nitrocellulose membrane:
1)使用100μL二甲基亚砜(DMSO)溶解2mg的AMB,对其进行超声处理促进溶解;1) Use 100 μL dimethyl sulfoxide (DMSO) to dissolve 2 mg of AMB, and perform ultrasonic treatment to promote dissolution;
2)将80mg的EDC和48mg的NHS溶解于2-(N-吗啉)乙磺酸(100 mM MES,pH 6.0)缓冲液中;2) Dissolve 80 mg of EDC and 48 mg of NHS in 2-(N-morpholino)ethanesulfonic acid (100 mM MES, pH 6.0) buffer;
3)混合1)2)中的两种溶液,并于37℃下混合搅拌20min,活化AMB分子中的羧基;3) Mix the two solutions in 1) 2) and mix and stir at 37°C for 20 minutes to activate the carboxyl groups in the AMB molecules;
4)向上述溶液中加入10μL树枝状聚合物溶液,于室温下反应过夜;4) Add 10 μL of dendrimer solution to the above solution and react at room temperature overnight;
5)然后使用透析管对上述反应溶液进行透析,通过更换水来去除多余的反应物(透析时间分别为1h、2h、4h、4h),收集透析后的探针溶液;5) Then use a dialysis tube to dialyze the above reaction solution, remove excess reactants by replacing water (dialysis times are 1h, 2h, 4h, 4h respectively), and collect the dialyzed probe solution;
6)硝酸纤维素膜在水中活化,将膜与探针分子溶液室温孵育过夜;6) Activate the nitrocellulose membrane in water, and incubate the membrane with the probe molecule solution at room temperature overnight;
7)孵育完成后用MES缓冲液洗涤两次,每次10min,然后使用磷酸盐缓冲液洗涤一次,洗涤时间为10min,将膜置于室温干燥;7) After incubation, wash twice with MES buffer for 10 minutes each time, then wash once with phosphate buffer for 10 minutes, and dry the membrane at room temperature;
实施例2:Example 2:
ADSP分子探针涂覆硝酸纤维素膜用于体液样本的外泌体捕获(以血浆样本为例):ADSP molecular probe coated nitrocellulose membrane is used to capture exosomes from body fluid samples (taking plasma samples as an example):
1)对血浆样本进行前处理,收集到的体液样本存储于-80℃,将其在4℃环境下融化,并在5000×g 4℃离心10min后取上清进行点样;1) Pre-process the plasma samples, store the collected body fluid samples at -80°C, thaw them at 4°C, and centrifuge them at 5000 × g at 4°C for 10 minutes, then take the supernatant for spotting;
2)超离血浆样本的制备:体液样本于2000g离心30min,取上清于20000g离心45min,取上清于110000g离心70min,弃上清后,沉淀用PBS吹打复溶,使用0.22的滤器进行过滤后于110000g离心70min,沉淀为外泌体,同时收集上清液作为阴性对照;2) Preparation of ultra-centrifuged plasma samples: centrifuge body fluid samples at 2000g for 30 minutes, take the supernatant and centrifuge at 20000g for 45 minutes, take the supernatant and centrifuge at 110000g for 70 minutes. After discarding the supernatant, the precipitate is redissolved by pipetting with PBS and filtered using a 0.22 filter. Then centrifuge at 110000g for 70 minutes to precipitate exosomes, and collect the supernatant as a negative control;
3)使用同等于超离前血浆量的PBS缓冲液复溶沉淀以保持与原血浆浓度相同;3) Use PBS buffer equivalent to the amount of plasma before ultrasonic separation to redissolve the pellet to maintain the same concentration as the original plasma;
4)血浆样品、超速离心得到的外泌体以及超离上清分别以0.2-2µL梯度直接点样在ADSP功能化NC膜上;4) Plasma samples, exosomes obtained by ultracentrifugation and supernatant were directly spotted on the ADSP functionalized NC membrane in a gradient of 0.2-2µL;
5)将样本点样到ADSP修饰的NC膜上后,在室温下等待样本干燥,然后用1%BSA的PBS缓冲液洗涤2次,每次5min;5) After spotting the sample onto the ADSP-modified NC membrane, wait for the sample to dry at room temperature, and then wash it twice with 1% BSA PBS buffer for 5 minutes each time;
6)将膜置于含有5%的脱脂奶粉的磷酸盐缓冲液中进行封闭30min,含有吐温的磷酸盐缓冲液洗涤3次,每次10min;6) Place the membrane in phosphate buffer containing 5% skimmed milk powder for blocking for 30 minutes, and wash 3 times with phosphate buffer containing Tween for 10 minutes each time;
7)使用外泌体的标志蛋白(CD9、CD81、CD63、TSG101等)进行一抗孵育,室温下孵育2h或4℃孵育过夜,用含有吐温的磷酸盐缓冲液洗涤3次,每次5min;7) Incubate with primary antibodies using exosome marker proteins (CD9, CD81, CD63, TSG101, etc.), incubate at room temperature for 2 hours or overnight at 4°C, and wash 3 times with phosphate buffer containing Tween, 5 minutes each time ;
8)然后,使用与一抗相对应二抗进行孵育,孵育时间为1h,用PBST洗3次,每次5min,并使用成像系统对蛋白信号进行定量扫描。(如图1所示)8) Then, use the secondary antibody corresponding to the primary antibody to incubate for 1 hour, wash with PBST three times, 5 minutes each time, and use an imaging system to quantitatively scan the protein signal. (As shown in Figure 1)
实施例3:Example 3:
ADSP分子探针涂覆硝酸纤维素膜对临床大批量样本的癌症标志蛋白的高通量检测:High-throughput detection of cancer marker proteins in large batches of clinical samples using ADSP molecular probes coated on nitrocellulose membranes:
1)对肝癌血浆样本进行前处理,收集到的血浆样本存储于-80℃,将其在4℃环境下融化,并在5000×g 4℃离心10min后取上清进行点样;1) Preprocess liver cancer plasma samples. The collected plasma samples are stored at -80°C, thawed at 4°C, and centrifuged at 5000×g for 10 minutes at 4°C. The supernatant is taken for spotting;
2)将1μL肝癌患者和非癌对照的血浆直接在ADSP修饰的NC膜上后,室温干燥,用1%的PBST洗涤2次,每次5min;2) Place 1 μL of plasma from liver cancer patients and non-cancer controls directly on the ADSP-modified NC membrane, dry at room temperature, and wash twice with 1% PBST for 5 minutes each time;
3)然后将膜置于含有5%的脱脂奶粉的PBS缓冲液中封闭30min,PBST洗3次,每次10min。3) Then place the membrane in PBS buffer containing 5% skimmed milk powder for 30 min, and wash with PBST 3 times, 10 min each time.
4)使用在癌症中高表达的蛋白进行一抗孵育,孵育时间为室温2h或者4℃孵育过夜,用PBST洗3次,每次5分钟;4) Incubate with primary antibodies using proteins highly expressed in cancer. The incubation time is 2 hours at room temperature or overnight at 4°C. Wash 3 times with PBST for 5 minutes each time;
5)然后,使用与一抗相对应二抗进行孵育,孵育时间为1h,并使用成像系统对蛋白信号进行定量扫描。(如图2所示)5) Then, use the secondary antibody corresponding to the primary antibody to incubate for 1 hour, and use an imaging system to quantitatively scan the protein signal. (as shown in picture 2)
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明的保护范围之内。The above descriptions are only preferred embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention shall be included in the protection of the present invention. within the range.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111661780.0A CN114323863B (en) | 2021-12-31 | 2021-12-31 | Preparation method and application of exosome array capture probe |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111661780.0A CN114323863B (en) | 2021-12-31 | 2021-12-31 | Preparation method and application of exosome array capture probe |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114323863A CN114323863A (en) | 2022-04-12 |
CN114323863B true CN114323863B (en) | 2023-12-22 |
Family
ID=81021030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111661780.0A Active CN114323863B (en) | 2021-12-31 | 2021-12-31 | Preparation method and application of exosome array capture probe |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114323863B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117363697A (en) * | 2023-10-10 | 2024-01-09 | 上海烈冰生物医药科技有限公司 | Preparation method of high-density probe magnetic beads for nucleic acid capture |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101528268A (en) * | 2006-09-05 | 2009-09-09 | 伯拉考开发股份有限公司 | Gas-filled microvesicles with polymer-modified lipids |
CN105849554A (en) * | 2013-10-24 | 2016-08-10 | 新加坡科技研究局 | Exosome recovery methods with low molecular weight organic zwitterions |
CN111019885A (en) * | 2019-11-14 | 2020-04-17 | 华南农业大学 | A kind of exosome derived from porcine endometrium and its extraction method and application |
CN113186166A (en) * | 2021-04-29 | 2021-07-30 | 南京鼓楼医院 | Hedgehog-shaped magnetic microsphere-based exosome enrichment method |
CN113388122A (en) * | 2021-06-29 | 2021-09-14 | 上海艾棵颂生物科技有限公司 | Electropositive surface exosome and preparation method and application thereof |
WO2021198954A1 (en) * | 2020-03-31 | 2021-10-07 | Universidade Do Minho | Exosome-enriched extracellualr vesicles isolation, method and uses thereof |
WO2021262706A1 (en) * | 2020-06-23 | 2021-12-30 | The Brigham And Women's Hospital, Inc. | Single molecule assays for ultrasensitive detection of biomolecules |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11266736B2 (en) * | 2008-04-17 | 2022-03-08 | Vin De Bona Trading Company Pte Ltd | Method of painting micro vesicles |
KR20130127276A (en) * | 2012-05-14 | 2013-11-22 | 삼성전자주식회사 | Methods for analysing exosome using fluorescent-labeled exosome |
DK2906717T3 (en) * | 2012-10-11 | 2019-04-01 | Vin De Bona Trading Company Pte Ltd | PROCEDURE FOR PAINTING MICROVESICS |
ES2912033T3 (en) * | 2012-10-23 | 2022-05-24 | Caris Science Inc | Aptamers and uses thereof |
EP3391051B1 (en) * | 2015-12-18 | 2020-02-05 | Universiteit Gent | Method and system for characterizing extracellular vesicles |
WO2018170332A1 (en) * | 2017-03-15 | 2018-09-20 | Nutech Ventures | Extracellular vesicles and methods of using |
US11344627B2 (en) * | 2017-06-27 | 2022-05-31 | Wisconsin Alumni Research Foundation | Dendrimer-exosome hybrid nanoparticles as a delivery platform |
US20190310172A1 (en) * | 2018-04-05 | 2019-10-10 | Caris Science, Inc. | Profiling extracellular vesicles |
US11988663B2 (en) * | 2018-12-18 | 2024-05-21 | The University Of Memphis Research Foundation | Compositions and methods for the detection and molecular profiling of membrane bound vesicles |
-
2021
- 2021-12-31 CN CN202111661780.0A patent/CN114323863B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101528268A (en) * | 2006-09-05 | 2009-09-09 | 伯拉考开发股份有限公司 | Gas-filled microvesicles with polymer-modified lipids |
CN105849554A (en) * | 2013-10-24 | 2016-08-10 | 新加坡科技研究局 | Exosome recovery methods with low molecular weight organic zwitterions |
CN111019885A (en) * | 2019-11-14 | 2020-04-17 | 华南农业大学 | A kind of exosome derived from porcine endometrium and its extraction method and application |
WO2021198954A1 (en) * | 2020-03-31 | 2021-10-07 | Universidade Do Minho | Exosome-enriched extracellualr vesicles isolation, method and uses thereof |
WO2021262706A1 (en) * | 2020-06-23 | 2021-12-30 | The Brigham And Women's Hospital, Inc. | Single molecule assays for ultrasensitive detection of biomolecules |
CN113186166A (en) * | 2021-04-29 | 2021-07-30 | 南京鼓楼医院 | Hedgehog-shaped magnetic microsphere-based exosome enrichment method |
CN113388122A (en) * | 2021-06-29 | 2021-09-14 | 上海艾棵颂生物科技有限公司 | Electropositive surface exosome and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN114323863A (en) | 2022-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6712737B2 (en) | Biomarker, disease-related gene search method, and renal cancer marker | |
KR100209072B1 (en) | Methods for preparing biologically active reagents from succinimide-containing polymers, analytical elements, and methods of using the same | |
JP7511938B2 (en) | Apparatus for producing exosome liquid biopsy samples and method for producing same | |
Fan et al. | Exosome-specific tumor diagnosis via biomedical analysis of exosome-containing microRNA biomarkers | |
CN106461681B (en) | Biomarker and application thereof for diagnosing vascular diseases | |
CN114323863B (en) | Preparation method and application of exosome array capture probe | |
CN113049552B (en) | Quantitative detection method of MUC1 protein based on exosome detection and single-molecule fluorescent bleaching technology | |
Feng et al. | Simultaneous detection of two extracellular vesicle subpopulations in saliva assisting tumor T staging of oral squamous cell carcinoma | |
JPS58500837A (en) | Detection of malignant tumor cells | |
JPH05500858A (en) | Diagnostic tools for demyelinating neurological disorders, especially multiple sclerosis | |
CN110128543A (en) | A kind of imitation virus vesicle and its preparation method and its use | |
WO2006047928A1 (en) | Preparation and application of the type of cell detecting immunoassaying chips for cancer and their use | |
JP2779178B2 (en) | How to increase the sensitivity of your target ligand assay | |
CN109580951A (en) | The kit and its application method of multispecific antibody joint-detection early liver cancer marker | |
JP7081861B1 (en) | A kit for testing urothelial cancer that identifies Neu5Gc in urine modified with UMOD based on LIP, and a method for producing the same. | |
Huo et al. | A sequential separation strategy for facile isolation and comprehensive analysis of human urine N-glycoproteome | |
CN117890592A (en) | A biomarker for screening and diagnosing multiple cancers and its application | |
WO2021213298A1 (en) | Immunofluorescence kit for detecting ca199 expression of peripheral blood circulating tumor cells of pancreatic cancer patient and detection method | |
JPH0616048B2 (en) | Immunological measurement of fibronectin | |
CN111393524B (en) | In-situ detection method of Alzheimer brain tissue Abeta protein based on metal marker | |
JPS58135460A (en) | Method and kit for diagnosing cancer | |
CN107674884A (en) | It is a kind of to be used to detect pancreatic cancer marker REG1A biotinylation liposome and its preparation method and application | |
JPH01163664A (en) | Diagnosing drug for malignant tumor and/or virus disease | |
WO2007069423A1 (en) | Diagnostic marker for allergy | |
CN113826013B (en) | Polypeptide magnetic nanoparticles, preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |